IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJ-D-16-00259

Neoatherosclerosis: an emerging and conceptually unexpected cause of very late bioresorbable vascular scaffold failure

Nick Hiltrop1*, MD; Walter Desmet1,2, MD, PhD, FESC; Tom Adriaenssens1,2, MD, PhD; Johan Bennett1,2, MD

A 31-year-old male who had crescendo angina for three weeks experienced a non-ST-elevation myocardial infarction (CK-MB 8.7, troponin I 0.24 ng/mL) due to an in-scaffold proximal left anterior descending occlusion 30 months after uncomplicated implantation of a 3.5×18 mm Absorb™ bioresorbable vascular scaffold (BVS; Abbott Vascular, Santa Clara, CA, USA) in a soft tissue culprit lesion. Platinum BVS markers are indicated (white arrows) (Panel A, Panel B, Moving image 1). After gentle predilation, optical coherence tomography (ILUMIEN™ OPTIS™; St. Jude Medical, St. Paul, MN, USA) revealed extensive lipid deposition with thin-cap fibroatheroma (TCFA) (Panel I, Moving image 2). Cross-sectional levels are indicated (Panel J). Residual thrombus (asterisk) and suboptimal blood clearance due to restenosis precluded optimal image acquisition. Critical BVS restenosis consisted of homogeneous neointimal hyperplasia (black arrows) adjacent to areas with heterogeneous neointima (Neo) and accumulations of macrophages (green arrows), suggesting neoatherosclerosis as the underlying mechanism of scaffold failure (Panel D-Panel H). Remnant scaffold struts (red arrowheads), visible 30 months after implantation, did not suggest late structural discontinuity. White thrombus (white arrowhead) adjacent to a TCFA was noticed, although predilation precludes a definite diagnosis of plaque rupture (Panel H). Implantation of a 3.0×26 mm DES (dotted line) and post-dilation using a 3.5 mm non-compliant balloon showed an optimal result (Panel C, Moving image 3).

Larger OCT series did not identify neoatherosclerosis as an underlying mechanism in late/very late BVS failure. However, delayed scaffold bioresorption in diseased coronary arteries might cause higher than expected low-grade hypersensitivity reactions and peri-scaffold inflammation, resulting in neoatherosclerosis in BVS. Neoatherosclerosis might become a conceptually unexpected mechanism of late/very late scaffold failure. Long-term follow-up is indicated.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Angiography at presentation showing a thrombotic occlusion of the proximal left anterior descending coronary artery, within the previously implanted 3.5×18 mm bioresorbable vascular scaffold (BVS) (Absorb; Abbott Vascular). Right anterior oblique view with caudal inclination.

Moving image 2. Optical coherence tomography (ILUMIEN OPTIS; St. Jude Medical) after gentle predilation with a 2.0 mm balloon, revealing extensive lipid accumulation with TCFA in the proximal LAD coronary artery, without clear evidence of plaque rupture. Critical BVS restenosis was seen, consisting of areas with homogeneous neointimal hyperplasia, adjacent to areas with more heterogeneous neointima with high signal attenuation and accumulation of macrophages suggesting the presence of neoatherosclerosis. Mural white thrombus in an area with TCFA can be seen within the BVS, although predilation and the presence of residual thrombus precludes the definite diagnosis of a neoatherosclerotic ruptured TCFA. Remnant scaffold struts, still visible 30 months after implantation, did not suggest late structural discontinuity.

Moving image 3. Angiography after predilation with a 2.0 mm balloon and implantation of a 3.0×26 mm drug-eluting metallic stent. Post-dilation was performed using a 3.5 mm non-compliant balloon, restoring TIMI 3 flow. Right anterior oblique view with caudal inclination.

Supplementary data

To read the full content of this article, please download the PDF.

Angiography at presentation showing a thrombotic occlusion of the proximal left anterior descending coronary artery, within the previously implanted 3.5×18 mm bioresorbable vascular scaffold (BVS) (Absorb; Abbott Vascular). Right anterior oblique view with caudal inclination.

Optical coherence tomography (ILUMIEN OPTIS; St. Jude Medical) after gentle predilation with a 2.0 mm balloon, revealing extensive lipid accumulation with TCFA in the proximal LAD coronary artery, without clear evidence of plaque rupture. Critical BVS restenosis was seen, consisting of areas with homogeneous neointimal hyperplasia, adjacent to areas with more heterogeneous neointima with high signal attenuation and accumulation of macrophages suggesting the presence of neoatherosclerosis. Mural white thrombus in an area with TCFA can be seen within the BVS, although predilation and the presence of residual thrombus precludes the definite diagnosis of a neoatherosclerotic ruptured TCFA. Remnant scaffold struts, still visible 30 months after implantation, did not suggest late structural discontinuity.

Angiography after predilation with a 2.0 mm balloon and implantation of a 3.0×26 mm drug-eluting metallic stent. Post-dilation was performed using a 3.5 mm non-compliant balloon, restoring TIMI 3 flow. Right anterior oblique view with caudal inclination.

Volume 12 Number 16
Mar 20, 2017
Volume 12 Number 16
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I1A14 May 19, 2015
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity
Azzalini L et al
free

10.4244/EIJV11SVA42 May 19, 2015
Treatment of bioresorbable scaffold failure
Felix C et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I10A201 Nov 20, 2016
Ruptured “non-culprit” in-stent neoatherosclerosis during ST-segment elevation acute myocardial infarction
Cuesta J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I7A142 Sep 18, 2016
Plaque protrusion compromising bioresorbable coronary scaffold patency
Floré V et al
free
Trending articles
310.43

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
28

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved